Ignite Creation Date:
2024-05-06 @ 8:26 PM
Last Modification Date:
2024-10-26 @ 3:28 PM
Study NCT ID:
NCT06388720
Status:
RECRUITING
Last Update Posted:
2024-04-29
First Post:
2024-04-24
Brief Title:
The Clinical Effectiveness and Safety of Intravesical Mitomycin-C and Gemcitabine Sequential Therapy
Sponsor:
National Cancer Center Korea
Organization:
National Cancer Center Korea
Organization Data
Organization:
National Cancer Center Korea
Class:
OTHER_GOV
Study ID:
NCC2024-0026
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
National Cancer Center Korea
Lead Sponsor Class:
OTHER_GOV
Responsible Party:
Ho Kyung Seo
Responsible Party Title:
Primary Investigator
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
National Cancer Center Korea
Old Name:
None
Old Organization:
None